Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
53,08 CN¥
+0,34%
(+0,18) 1D
16 հոկ, 15:04:30 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
52,89 CN¥
High
53,66 CN¥
Low
52,52 CN¥
Mkt. cap
94,71 մլրդ
Avg. vol.
7,52 մլն
Volume
12,92 մլն
Dividend
4,94%
Quarterly dividend
0,66 CN¥
Ex-dividend date
30 ապր, 2026 թ.
P/E ratio
18,14
52-wk high
58,20 CN¥
52-wk low
46,29 CN¥
EPS
2,93 CN¥
Shares outstanding
1,78 մլրդ
No. of employees
9 հզր
Open
52,89 CN¥
High
53,66 CN¥
Low
52,52 CN¥
Mkt. cap
94,71 մլրդ
Avg. vol.
7,52 մլն
Volume
12,92 մլն
Dividend
4,94%
Quarterly dividend
0,66 CN¥
Ex-dividend date
30 ապր, 2026 թ.
P/E ratio
18,14
52-wk high
58,20 CN¥
52-wk low
46,29 CN¥
EPS
2,93 CN¥
Shares outstanding
1,78 մլրդ
No. of employees
9 հզր
News stories
From web sources and news partners
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9,29 հզր
Founded1902
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
9,40 մլրդ
10,53 մլրդ
11,60 մլրդ
10,28 մլրդ
Cost of goods sold
6,70 մլրդ
7,85 մլրդ
8,05 մլրդ
7,28 մլրդ
Cost of revenue
6,70 մլրդ
7,85 մլրդ
8,05 մլրդ
7,28 մլրդ
Research and development expenses
79,10 մլն
115,55 մլն
76,79 մլն
112,78 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,39 մլրդ
2,37 մլրդ
1,28 մլրդ
1,50 մլրդ
Operating expense
1,33 մլրդ
2,67 մլրդ
1,44 մլրդ
1,64 մլրդ
Total operating expenses
8,03 մլրդ
10,52 մլրդ
9,48 մլրդ
8,92 մլրդ
Operating income
1,37 մլրդ
12,79 մլն
2,12 մլրդ
1,36 մլրդ
Other non operating income
-43,28 մլն
135,88 մլն
-17,44 մլն
37,87 մլն
EBT including unusual items
1,38 մլրդ
428,17 մլն
2,36 մլրդ
1,92 մլրդ
EBT excluding unusual items
1,47 մլրդ
233,79 մլն
2,35 մլրդ
1,74 մլրդ
Income tax expense
238,66 մլն
27,40 մլն
330,30 մլն
255,01 մլն
Effective tax rate
17,25%
6,40%
13,99%
13,27%
Other operating expenses
-18,86 մլն
129,96 մլն
6,54 մլն
116,66 մլն
Net income
1,14 մլրդ
376,37 մլն
2,04 մլրդ
1,66 մլրդ
Net profit margin
12,18%
3,57%
17,56%
16,18%
Earnings per share
0,61
0,18
1,10
0,87
Interest and investment income
136,98 մլն
107,27 մլն
253,40 մլն
367,65 մլն
Interest expense
-4,39 մլն
-8,83 մլն
-5,09 մլն
-5,15 մլն
Net interest expenses
132,58 մլն
98,43 մլն
248,31 մլն
362,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,42 մլրդ
70,91 մլն
2,18 մլրդ
1,43 մլրդ
Gain or loss from assets sale
2,26 մլն
-8,17 մլն
-
-3,05 հզր
AI content may include mistakes. Learn more
Google Apps